Akebia Therapeutics, INC.
Based in MA
🤖
AI Overview
With $9.8M in lobbying spend across 31 quarterly filings, Akebia Therapeutics, INC is one of the biggest lobbying spenders in Washington. Their lobbying covers 3 issue areas. Active from 2018 to 2025.
$9.8M
Total Spend
8
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $230K |
| 2019 | $1.8M |
| 2020 | $1.6M |
| 2021 | $1.3M |
| 2022 | $1.3M |
| 2023 | $1.1M |
| 2024 | $1.1M |
| 2025 | $1.3M |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Budget/Appropriations, Health Issues
- •End Stage Renal Disease (ESRD) and kidney disease, generally; and issues specifically relating to ESRD drugs, innovation, and reimbursement (including Medicare coverage and reimbursement)
- •Implementation of P.L. 115-123, the Bipartisan Budget Act (BBA) of 2018.
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.